Fresenius SE KGaA (XSWX:FRE) GF Value Rank: 7 (As of Jun. 27, 2026) — 13% Below Median


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF36.15
GF Value CHF33.18
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA GF Value Rank?

Fresenius SE KGaA XSWX:FRE 71 GF Value Rank is 7 as of Jun. 27, 2026, which is 13% below its 10-year median of 8.00. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.18 (Fairly Valued). The stock has 5 warning signs investors should review.

Fresenius SE KGaA has the GF Value Rank of 7.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Fresenius SE KGaA GF Value Rank Related Terms

XSWX:FRE vs HCA, THC, DVA: GF Value Rank Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius SE KGaA GF Value Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's GF Value Rank falls into.


XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 7 mean?
Fresenius SE KGaA (XSWX:FRE) has a GF Value Rank of 7 as of Jun. 27, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Fresenius SE KGaA and its competitors. This is 13% below median its historical median of 8.00. Over the past decade, Fresenius SE KGaA's GF Value Rank has ranged from 2.00 to 10.00.
Is Fresenius SE KGaA's GF Value Rank too high?
Fresenius SE KGaA's current GF Value Rank of 7 is 13% below median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 10.00. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's GF Value Rank compare to HCA and THC?
Fresenius SE KGaA's GF Value Rank of 7 can be compared against companies in the Healthcare Providers & Services industry. Historically, Fresenius SE KGaA's own GF Value Rank has ranged from 2.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Healthcare Providers & Services company?
A good GF Value Rank depends on the Healthcare Providers & Services industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current GF Value Rank is 7, which is 13% below median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF33.18, compared to a current price of CHF36.15 — trading 9% above its estimated fair value. The current GF Value Rank is 7, which is 13% below median its 10-year median of 8.00. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current GF Value Rank is 7 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF36.15 is trading 9% above its estimated GF Value™ of CHF33.18. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XSWX:FRE:

  • GF Value Rank: 7 (13% below median its 10-year median of 8.00)
  • GF Value™: CHF33.18 vs. price of CHF36.15 (9% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF36.15
Price
CHF33.18
GF Value